294 related articles for article (PubMed ID: 1942252)
21. Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat.
Sikder SK; Mitra D; Laurence J
Arch Virol; 1994; 137(1-2):139-47. PubMed ID: 7979987
[TBL] [Abstract][Full Text] [Related]
22. Circularization of human immunodeficiency virus type 1 DNA in vitro.
Farnet CM; Haseltine WA
J Virol; 1991 Dec; 65(12):6942-52. PubMed ID: 1834863
[TBL] [Abstract][Full Text] [Related]
23. CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
Dahiya S; Liu Y; Nonnemacher MR; Dampier W; Wigdahl B
PLoS One; 2014; 9(2):e88116. PubMed ID: 24551078
[TBL] [Abstract][Full Text] [Related]
24. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
25. The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication.
Colin L; Vandenhoudt N; de Walque S; Van Driessche B; Bergamaschi A; Martinelli V; Cherrier T; Vanhulle C; Guiguen A; David A; Burny A; Herbein G; Pancino G; Rohr O; Van Lint C
PLoS One; 2011 Apr; 6(4):e19084. PubMed ID: 21526160
[TBL] [Abstract][Full Text] [Related]
26. Conserved chromatin structure in c-myc 5'flanking DNA after viral transduction.
Kumar S; Leffak M
J Mol Biol; 1991 Nov; 222(1):45-57. PubMed ID: 1942068
[TBL] [Abstract][Full Text] [Related]
27. Intragenic HIV-1 env sequences that enhance gag expression.
Suptawiwat O; Sutthent R; Lee TH; Auewarakul P
Virology; 2003 Apr; 309(1):1-9. PubMed ID: 12726721
[TBL] [Abstract][Full Text] [Related]
28. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
Furtado MR; Balachandran R; Gupta P; Wolinsky SM
Virology; 1991 Nov; 185(1):258-70. PubMed ID: 1926777
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the internal promoter of simian foamy viruses.
Campbell M; Renshaw-Gegg L; Renne R; Luciw PA
J Virol; 1994 Aug; 68(8):4811-20. PubMed ID: 8035481
[TBL] [Abstract][Full Text] [Related]
30. Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA.
Ogata T; Kozuka T; Kanda T
J Virol; 2003 Aug; 77(16):9000-7. PubMed ID: 12885916
[TBL] [Abstract][Full Text] [Related]
31. T cell receptor beta gene has two downstream DNase I hypersensitive regions. Possible mechanisms of tissue- and stage-specific gene regulation.
Hashimoto Y
J Exp Med; 1989 Jun; 169(6):2097-107. PubMed ID: 2525173
[TBL] [Abstract][Full Text] [Related]
32. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
33. Promoter sequence containing (CT)n.(GA)n repeats is critical for the formation of the DNase I hypersensitive sites in the Drosophila hsp26 gene.
Lu Q; Wallrath LL; Allan BD; Glaser RL; Lis JT; Elgin SC
J Mol Biol; 1992 Jun; 225(4):985-98. PubMed ID: 1377279
[TBL] [Abstract][Full Text] [Related]
34. Cell-to-cell contact activates the long terminal repeat of human immunodeficiency virus 1 through its kappaB motif.
Faure E; Lecine P; Lipcey C; Champion S; Imbert J
Eur J Biochem; 1997 Mar; 244(2):568-74. PubMed ID: 9119025
[TBL] [Abstract][Full Text] [Related]
35. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
Lacoste J; D'Addario M; Roulston A; Wainberg MA; Hiscott J
J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
[TBL] [Abstract][Full Text] [Related]
36. Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.
Reicin AS; Kalpana G; Paik S; Marmon S; Goff S
J Virol; 1995 Sep; 69(9):5904-7. PubMed ID: 7637038
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation.
Pion M; Jordan A; Biancotto A; Dequiedt F; Gondois-Rey F; Rondeau S; Vigne R; Hejnar J; Verdin E; Hirsch I
J Virol; 2003 Apr; 77(7):4025-32. PubMed ID: 12634362
[TBL] [Abstract][Full Text] [Related]
38. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.
Demarchi F; D'Agaro P; Falaschi A; Giacca M
J Virol; 1993 Dec; 67(12):7450-60. PubMed ID: 8230466
[TBL] [Abstract][Full Text] [Related]
39. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.
Roebuck KA; Brenner DA; Kagnoff MF
J Clin Invest; 1993 Sep; 92(3):1336-48. PubMed ID: 8376588
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
Jeang KT; Chun R; Lin NH; Gatignol A; Glabe CG; Fan H
J Virol; 1993 Oct; 67(10):6224-33. PubMed ID: 7690421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
